| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Diclofenac |
| Brand | Itami® |
| Indication | For the local symptomatic and short-term treatment (max. 7 days) of pain in acute strains, sprains or bruises of the extremities following blunt trauma e.g. sports injuries in adolescents aged from 16 years and adults |
| Assessment Process | |
| Rapid review commissioned | 31/12/2018 |
| Rapid review completed | 17/01/2019 |
| Rapid review outcome | A full HTA is not recommended. The NCPE recommends that diclofenac 140mg Medicated Plaster (Itami®) not be considered for reimbursement. This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013. |
